Published in JMIR Ment Health on March 24, 2015
New Tools for New Research in Psychiatry: A Scalable and Customizable Platform to Empower Data Driven Smartphone Research. JMIR Ment Health (2016) 1.08
Realizing the potential of mobile mental health: new methods for new data in psychiatry. Curr Psychiatry Rep (2015) 0.98
A Systematic Review of Cognitive Behavioral Therapy and Behavioral Activation Apps for Depression. PLoS One (2016) 0.86
Does a Mobile Phone Depression-Screening App Motivate Mobile Phone Users With High Depressive Symptoms to Seek a Health Care Professional's Help? J Med Internet Res (2016) 0.81
Depression Screening Using Daily Mental-Health Ratings from a Smartphone Application for Breast Cancer Patients. J Med Internet Res (2016) 0.77
Usability Evaluation of a Mobile Monitoring System to Assess Symptoms After a Traumatic Injury: A Mixed-Methods Study. JMIR Ment Health (2016) 0.77
Methodology and Reporting of Mobile Heath and Smartphone Application Studies for Schizophrenia. Harv Rev Psychiatry (2017) 0.75
A Digital Tool to Promote Alcohol and Drug Use Screening, Brief Intervention, and Referral to Treatment Skill Translation: A Mobile App Development and Randomized Controlled Trial Protocol. JMIR Res Protoc (2017) 0.75
Treating major depression with yoga: A prospective, randomized, controlled pilot trial. PLoS One (2017) 0.75
New dimensions and new tools to realize the potential of RDoC: digital phenotyping via smartphones and connected devices. Transl Psychiatry (2017) 0.75
What Do Men Want from a Health Screening Mobile App? A Qualitative Study. PLoS One (2017) 0.75
Information technology-enabled team-based, patient-centered care: The example of depression screening and management in cancer care. Health Policy Technol (2016) 0.75
Data Collection for Mental Health Studies Through Digital Platforms: Requirements and Design of a Prototype. JMIR Res Protoc (2017) 0.75
Immediate Mood Scaler: Tracking Symptoms of Depression and Anxiety Using a Novel Mobile Mood Scale. JMIR Mhealth Uhealth (2017) 0.75
The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med (2001) 76.04
Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010. Lancet (2013) 16.76
Screening for depression in medical settings with the Patient Health Questionnaire (PHQ): a diagnostic meta-analysis. J Gen Intern Med (2007) 5.24
Measuring depression outcome with a brief self-report instrument: sensitivity to change of the Patient Health Questionnaire (PHQ-9). J Affect Disord (2004) 4.66
Smartphones for smarter delivery of mental health programs: a systematic review. J Med Internet Res (2013) 3.76
In search of a few good apps. JAMA (2014) 3.61
Harnessing context sensing to develop a mobile intervention for depression. J Med Internet Res (2011) 3.44
Feasibility, acceptability, and preliminary efficacy of a smartphone intervention for schizophrenia. Schizophr Bull (2014) 2.53
Assessing depression in primary care with the PHQ-9: can it be carried out over the telephone? J Gen Intern Med (2005) 2.10
Accuracy of reports of lifetime mental and physical disorders: results from the Baltimore Epidemiological Catchment Area study. JAMA Psychiatry (2014) 1.93
Smartphone ownership and interest in mobile applications to monitor symptoms of mental health conditions. JMIR Mhealth Uhealth (2014) 1.74
Systematic use of patient-rated depression severity monitoring: is it helpful and feasible in clinical psychiatry? Psychiatr Serv (2008) 1.73
A comparison of two delivery modalities of a mobile phone-based assessment for serious mental illness: native smartphone application vs text-messaging only implementations. J Med Internet Res (2013) 1.58
Patient Smartphone Ownership and Interest in Mobile Apps to Monitor Symptoms of Mental Health Conditions: A Survey in Four Geographically Distinct Psychiatric Clinics. JMIR Ment Health (2014) 1.51
Depression screening using the Patient Health Questionnaire-9 administered on a touch screen computer. Psychooncology (2009) 1.44
Smartphone data as objective measures of bipolar disorder symptoms. Psychiatry Res (2014) 1.39
Mood disorders in everyday life: a systematic review of experience sampling and ecological momentary assessment studies. Clin Psychol Rev (2012) 1.29
The SmartCAT: an m-health platform for ecological momentary intervention in child anxiety treatment. Telemed J E Health (2014) 1.12
Behavioural activation versus mindfulness-based guided self-help treatment administered through a smartphone application: a randomised controlled trial. BMJ Open (2014) 1.11
A Pilot Study of Mood Ratings Captured by Mobile Phone Versus Paper-and-Pencil Mood Charts in Bipolar Disorder. J Dual Diagn (2012) 1.07
Time varying prediction of thoughts of death and suicidal ideation in adolescents: weekly ratings over 6-month follow-up. J Clin Child Adolesc Psychol (2012) 0.96
Behavioral screening measures delivered with a smartphone app: psychometric properties and user preference. J Nerv Ment Dis (2013) 0.91
Validity of the Patient Health Questionnaire, PHQ-9, administered through interactive-voice-response technology. J Telemed Telecare (2012) 0.83
Longitudinal course and predictors of suicidal ideation in a rural community sample. Aust N Z J Psychiatry (2013) 0.81
No personalization without participation: on the active contribution of psychiatric patients to the development of a mobile application for mental health. BMC Med Inform Decis Mak (2013) 0.80
Association of aphthous ulcers with self-reported symptoms of depression in a sample of smartphone users. Ann Clin Psychiatry (2013) 0.79
Use of mental health telemetry to enhance identification and predictive value of early changes during augmentation treatment of major depression. J Clin Psychopharmacol (2013) 0.79
Patient Smartphone Ownership and Interest in Mobile Apps to Monitor Symptoms of Mental Health Conditions: A Survey in Four Geographically Distinct Psychiatric Clinics. JMIR Ment Health (2014) 1.51
Mobile phone-based interventions for mental health: A systematic meta-review of 14 meta-analyses of randomized controlled trials. PLOS Digit Health (2022) 0.75